Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Hubert, Dominique; Marguet, Christophe; Benichou, Jacques; DeSouza, Cynthia; Payen-Champenois, Catherine; Kinnman, Nils; Chandarana, Keval; Munck, Anne; Fajac, Isabelle

Hubert, Dominique; Marguet, Christophe; Benichou, Jacques; DeSouza, Cynthia; Payen-Champenois, Catherine; Kinnman, Nils; Chandarana, Keval; Munck, Anne; Fajac, Isabelle.

Afiliación

Hubert D; Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. dominique.hubert@aphp.fr.
Marguet C; Pediatric Respiratory Diseases and Cystic Fibrosis Center, Rouen University Hospital, INSERM CIC1404, EA 2656 UNI ROUEN, Normandy University, Rouen, France.
Benichou J; Department of Biostatistics and Clinical Research, Rouen University Hospital and INSERM U 1018, University of Rouen, Rouen, France.
DeSouza C; Independent Consultant, Boston, MA, USA.
Payen-Champenois C; Vertex Pharmaceuticals (France), Paris, France.
Kinnman N; Vertex Pharmaceuticals (Europe) Limited, London, UK.
Chandarana K; Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
Munck A; Cystic Fibrosis Center, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France.
Fajac I; Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Pulm Ther ; 7(2): 455-468, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34101145

Palabras clave

Adults; Children; Cystic fibrosis; Exacerbation; Ivacaftor; Lung function; Real-world experience

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Pulm Ther Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google